News summarySEC EDGARNov 10, 2026, 12:00 PM
Elevance Health, 8-K (7.01): Regulation FD disclosure
Elevance Health reaffirmed 2026 guidance for at least $22.00 in shareholders’ earnings per diluted share, including about $7.00 of net unfavorable items, adjusted earnings of at least $29.00 per diluted share, and a benefit expense ratio of 90.2% plus or minus 50 basis points.